Eton Pharmaceuticals Statistics
Total Valuation
ETON has a market cap or net worth of $528.31 million. The enterprise value is $540.96 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ETON has 26.82 million shares outstanding. The number of shares has increased by 1.83% in one year.
| Current Share Class | 26.82M |
| Shares Outstanding | 26.82M |
| Shares Change (YoY) | +1.83% |
| Shares Change (QoQ) | +2.87% |
| Owned by Insiders (%) | 5.17% |
| Owned by Institutions (%) | 31.79% |
| Float | 20.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 38.25 |
| PS Ratio | 10.67 |
| Forward PS | 5.92 |
| PB Ratio | 21.61 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 95.71 |
| P/OCF Ratio | 95.50 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 180,321.48, with an EV/FCF ratio of 98.00.
| EV / Earnings | n/a |
| EV / Sales | 11.19 |
| EV / EBITDA | 180,321.48 |
| EV / EBIT | n/a |
| EV / FCF | 98.00 |
Financial Position
The company has a current ratio of 1.97, with a Debt / Equity ratio of 1.23.
| Current Ratio | 1.97 |
| Quick Ratio | 1.33 |
| Debt / Equity | 1.23 |
| Debt / EBITDA | 353.87 |
| Debt / FCF | 5.45 |
| Interest Coverage | -0.61 |
Financial Efficiency
Return on equity (ROE) is -22.95% and return on invested capital (ROIC) is -3.08%.
| Return on Equity (ROE) | -22.95% |
| Return on Assets (ROA) | -2.02% |
| Return on Invested Capital (ROIC) | -3.08% |
| Return on Capital Employed (ROCE) | -3.16% |
| Revenue Per Employee | $1.56M |
| Profits Per Employee | -$147,871 |
| Employee Count | 31 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 2.52 |
Taxes
In the past 12 months, ETON has paid $89,000 in taxes.
| Income Tax | 89,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +442.70% in the last 52 weeks. The beta is 1.23, so ETON's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | +442.70% |
| 50-Day Moving Average | 14.81 |
| 200-Day Moving Average | 11.20 |
| Relative Strength Index (RSI) | 75.46 |
| Average Volume (20 Days) | 275,498 |
Short Selling Information
The latest short interest is 702,458, so 2.62% of the outstanding shares have been sold short.
| Short Interest | 702,458 |
| Short Previous Month | 402,632 |
| Short % of Shares Out | 2.62% |
| Short % of Float | 3.39% |
| Short Ratio (days to cover) | 2.79 |
Income Statement
In the last 12 months, ETON had revenue of $48.33 million and -$4.58 million in losses. Loss per share was -$0.18.
| Revenue | 48.33M |
| Gross Profit | 28.27M |
| Operating Income | -1.85M |
| Pretax Income | -6.39M |
| Net Income | -4.58M |
| EBITDA | 3,000 |
| EBIT | -1.85M |
| Loss Per Share | -$0.18 |
Full Income StatementBalance Sheet
The company has $17.42 million in cash and $30.08 million in debt, giving a net cash position of -$12.66 million or -$0.47 per share.
| Cash & Cash Equivalents | 17.42M |
| Total Debt | 30.08M |
| Net Cash | -12.66M |
| Net Cash Per Share | -$0.47 |
| Equity (Book Value) | 24.45M |
| Book Value Per Share | 0.91 |
| Working Capital | 24.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $5.53 million and capital expenditures -$12,000, giving a free cash flow of $5.52 million.
| Operating Cash Flow | 5.53M |
| Capital Expenditures | -12,000 |
| Free Cash Flow | 5.52M |
| FCF Per Share | $0.21 |
Full Cash Flow StatementMargins
Gross margin is 58.49%, with operating and profit margins of -3.83% and -9.49%.
| Gross Margin | 58.49% |
| Operating Margin | -3.83% |
| Pretax Margin | -9.30% |
| Profit Margin | -9.49% |
| EBITDA Margin | 0.01% |
| EBIT Margin | -3.83% |
| FCF Margin | 11.42% |